IL113869A - Acylated enol derivatives as prodrugs of elastase inhibitors - Google Patents

Acylated enol derivatives as prodrugs of elastase inhibitors

Info

Publication number
IL113869A
IL113869A IL11386995A IL11386995A IL113869A IL 113869 A IL113869 A IL 113869A IL 11386995 A IL11386995 A IL 11386995A IL 11386995 A IL11386995 A IL 11386995A IL 113869 A IL113869 A IL 113869A
Authority
IL
Israel
Prior art keywords
prodrugs
elastase inhibitors
enol derivatives
acylated enol
acylated
Prior art date
Application number
IL11386995A
Other languages
English (en)
Other versions
IL113869A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL113869A0 publication Critical patent/IL113869A0/xx
Publication of IL113869A publication Critical patent/IL113869A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11386995A 1994-06-02 1995-05-26 Acylated enol derivatives as prodrugs of elastase inhibitors IL113869A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25279894A 1994-06-02 1994-06-02
US42085995A 1995-04-19 1995-04-19

Publications (2)

Publication Number Publication Date
IL113869A0 IL113869A0 (en) 1995-08-31
IL113869A true IL113869A (en) 2000-01-31

Family

ID=26942673

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11386995A IL113869A (en) 1994-06-02 1995-05-26 Acylated enol derivatives as prodrugs of elastase inhibitors

Country Status (20)

Country Link
US (2) US5698523A (fr)
EP (1) EP0762887B1 (fr)
JP (1) JP4221059B2 (fr)
KR (1) KR100367389B1 (fr)
CN (1) CN1149833A (fr)
AT (1) ATE206055T1 (fr)
AU (1) AU696292B2 (fr)
CA (1) CA2191844C (fr)
DE (1) DE69522940T2 (fr)
DK (1) DK0762887T3 (fr)
ES (1) ES2161293T3 (fr)
FI (1) FI964749A7 (fr)
HU (1) HU221310B1 (fr)
IL (1) IL113869A (fr)
MX (1) MX9606034A (fr)
NO (1) NO317185B1 (fr)
NZ (1) NZ287604A (fr)
PT (1) PT762887E (fr)
TW (1) TW406087B (fr)
WO (1) WO1995033478A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
DK0763055T3 (da) * 1994-06-02 2000-05-08 Merrell Pharma Inc Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
CN101534824A (zh) * 2006-11-17 2009-09-16 艾博特公司 作为化学活素受体拮抗剂的氨基吡咯烷

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
CA1267499A (fr) * 1983-07-12 1990-04-03 Cedric H. Hassall Amides et aldehydes peptidiques
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
EP0204571B1 (fr) * 1985-06-07 1992-01-22 Ici Americas Inc. Dérivés difluoro choisis
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
US4935405A (en) * 1986-10-31 1990-06-19 Pfizer Inc. Nor-statine and nor-cyclostatine polypeptides
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
EP0318318A1 (fr) * 1987-11-27 1989-05-31 Sensititre Limited Procédé d'essai d'urine et trousse
WO1992015605A2 (fr) * 1991-03-01 1992-09-17 Protein Engineering Corporation Inhibiteurs de l'elastase neutrophile et de la cathepsine g chez l'homme
US5162307A (en) * 1988-09-09 1992-11-10 Board Of Trustees Of The University Of Kentucky Polymer bound elastase inhibitors
EP0371179A1 (fr) * 1988-10-28 1990-06-06 Merrell Dow Pharmaceuticals Inc. Analogues des substrats de peptidases
EP0369391A3 (fr) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. Amides N-substitués
CA2021660A1 (fr) * 1989-07-26 1991-01-27 Philippe Bey Inhibiteurs de la peptidose
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
HUT62312A (en) * 1990-03-05 1993-04-28 Cephalon Inc Process for producing chymotrypsin-like proteases and their inhibitors
US5204462A (en) * 1990-03-30 1993-04-20 Japan Tobacco, Inc. 4h-3,1-benzoxazin-4-one derivative
CA2098702A1 (fr) * 1990-12-28 1992-06-29 James C. Powers Cetoamides, cetoacides et cetoesters de nature peptidique
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
ATE181925T1 (de) * 1991-05-23 1999-07-15 Merrell Pharma Inc Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau
AU655831B2 (en) * 1991-08-22 1995-01-12 Merrell Pharmaceuticals Inc. Novel orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
AU687449B2 (en) * 1993-10-01 1998-02-26 Aventis Inc. Inhibitors of beta-amyloid protein production
DK0763055T3 (da) * 1994-06-02 2000-05-08 Merrell Pharma Inc Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
HU221197B1 (en) * 1994-06-02 2002-08-28 Aventis Pharma Inc Elastase inhibitor tripeptides and pharmaceutical compositions comprising thereof
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.

Also Published As

Publication number Publication date
NO965099L (no) 1997-01-31
PT762887E (pt) 2002-01-30
NO317185B1 (no) 2004-09-13
FI964749L (fi) 1996-11-28
ES2161293T3 (es) 2001-12-01
JPH10501221A (ja) 1998-02-03
CA2191844C (fr) 2001-07-24
EP0762887A1 (fr) 1997-03-19
AU2636695A (en) 1996-01-04
AU696292B2 (en) 1998-09-03
HU221310B1 (en) 2002-09-28
ATE206055T1 (de) 2001-10-15
US5972897A (en) 1999-10-26
IL113869A0 (en) 1995-08-31
NZ287604A (en) 1998-12-23
MX9606034A (es) 1998-05-31
DK0762887T3 (da) 2002-01-14
WO1995033478A1 (fr) 1995-12-14
DE69522940T2 (de) 2002-04-04
FI964749A0 (fi) 1996-11-28
TW406087B (en) 2000-09-21
JP4221059B2 (ja) 2009-02-12
CA2191844A1 (fr) 1995-12-14
EP0762887B1 (fr) 2001-09-26
DE69522940D1 (de) 2001-10-31
US5698523A (en) 1997-12-16
FI964749A7 (fi) 1996-11-28
HU9603309D0 (en) 1997-01-28
HUT76131A (en) 1997-06-30
NO965099D0 (no) 1996-11-29
KR100367389B1 (ko) 2003-07-18
EP0762887A4 (fr) 1999-03-31
CN1149833A (zh) 1997-05-14

Similar Documents

Publication Publication Date Title
CA2289851A1 (fr) Composes et methodes d'inhibition de l'expression de vcam-1
GR3034208T3 (en) Human neutrophil elastase inhibitors
WO1998056771A3 (fr) Derives de piperazine et leur utilisation en tant qu'agents anti-inflammatoires
BG105880A (en) Compounds useful as anti-inflammatory agents
IL142908A0 (en) Compounds useful in the treatment of inflammatory diseases
EP0759750A4 (fr) Compositions pour le traitement de maladies inflammatoires chroniques
WO2001035950A3 (fr) Agent therapeutique a base d'amide et procedes de traitement des affections intestinales inflammatoires
GR3034575T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
AU2002233928A1 (en) Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
HUT76131A (en) Acylated enol derivatives as prodrugs of elastase inhibitors
MX9804265A (es) Derivados de enol acilado de a-cetoesteres y a-cetoamidas.
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
WO2002083700A3 (fr) Disaccharides hypersulfates et leur utilisation en traitement contre les inflammations
GB9421116D0 (en) Treatment of inflammatory dermatoses

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.